Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Drug Delivery Systems

Background:

• Controlled release systems are crucial for effective delivery of therapeutic proteins like bone morphogenetic protein (BMP).
• Poly(DL-lactide-co-glycolide) (PLGA) is a biodegradable polymer widely used in biomedical applications.
• Developing efficient BMP delivery systems is key for bone tissue engineering and regenerative medicine.

Purpose of the Study:

• To develop and characterize poly(DL-lactide-co-glycolide) (PLGA) capsules for the controlled release of bone morphogenetic protein (BMP).
• To evaluate the in vitro release kinetics and in vivo bone formation capacity of BMP-loaded PLGA capsules.

Main Methods:

• BMP was encapsulated into PLGA capsules using an interfacial precipitation method via a water-in-oil-in-water emulsion.
• PLGA capsule characteristics including surface morphology, particle size, and degradation rate were analyzed.
• In vitro BMP release was quantified using fluorescein isothiocyanate-labeled BMP.
• In vivo efficacy was assessed by subcutaneous implantation in rats and subsequent histological examination.

Main Results:

• PLGA capsules exhibited specific surface morphology and particle size distribution.
• The hydrolytic degradation rate of PLGA capsules was determined.
• In vitro studies showed an increase in BMP release from day 3 to day 5.
• Histological analysis at 3 weeks post-implantation revealed complete capsule digestion and significant new bone formation, including bone marrow.

Conclusions:

• PLGA encapsulation provides a viable method for controlled release of BMP.
• The developed BMP-loaded PLGA capsules demonstrate efficacy in inducing bone formation in vivo.
• This approach holds significant promise for clinical applications in bone regeneration.